Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfurol[2,3-b]quinoline derivates (n=6, 7). Part 5

Chemistry and Biodiversity

Volumn 5, Issue 2, 2008, Pages 267-278

  Chen, Yeh Long ^a   Lin, Huan Chin ^a   Yang, Chia Ning ^b   Lu, Pei Jung ^c,d   Tzeng, Cherng Chyi ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 [(3 CHLORO 7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO] 4,5 DIMETHOXYPHENYL]ETHANONE; 1 [3 [(3 CHLORO 6 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE; 1 [3 [(3 CHLORO 7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE; 1 [3 [(3 CHLORO 7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE OXIME; 1 [4 [(3 CHLORO 6 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE; 1 [4 [(3 CHLORO 7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE; 1 [4 [(3 CHLORO 7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE OXIME; 1 [4 [(7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE O METHYLOXIME; 1 [4 [(7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENYL]ETHANONE OXIME; 3 CHLORO 6 METHOXY N (4 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO 7 METHOXY N (2 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO 7 METHOXY N (3 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO 7 METHOXY N (3,4,5 TRIMETHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO 7 METHOXY N (4 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO 7 METHOXY N (4 METHYLPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO N (3,4 DIMETHOXYPHENYL) 7 METHOXYFURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO N (3,5 DIMETHOXYPHENYL) 7 METHOXYFURO[2,3 B]QUINOLIN 4 AMINE; 3 CHLORO N (4 FLUOROPHENYL) 7 METHOXYFURO[2,3 B]QUINOLIN 4 AMINE; 4 [(3 CHLORO 7 METHOXYFURO[2,3 B]QUINOLIN 4 YL)AMINO]PHENOL; 4 ANILINO N METHOXYFURO[2,3 B]QUINOLINE DERIVATIVE; 6 METHOXY N (4 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 7 METHOXY N (2 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 7 METHOXY N (4 METHOXYPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; 7 METHOXY N (4 METHYLPHENYL)FURO[2,3 B]QUINOLIN 4 AMINE; CAMPTOTHECIN; DOXORUBICIN; N (3,4 DIMETHOXYPHENYL) 7 METHOXYFURO[2,3 B]QUINOLIN 4 AMINE; N (4 FLUOROPHENYL) 7 METHOXYFURO[2,3 B]QUINOLIN 4 AMINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; 4 ANILINO N METHOXYFURO(2,3 B)QUINOLINE; 4-ANILINO-N-METHOXYFURO(2,3-B)QUINOLINE; ANILINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL CYCLE ARREST; CELL DEATH; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ESOPHAGUS CARCINOMA; HELA CELL; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MOUTH CARCINOMA; STOMACH ADENOCARCINOMA; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX CARCINOMA; CELL PROLIFERATION; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STANDARD; STEREOISOMERISM; SYNTHESIS; TUMOR CELL LINE;

ANILINE COMPOUNDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; QUINOLINES; REFERENCE STANDARDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54049117635     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200890024     Document Type: Article

References (14)

1. I. L. Chen, Y. L. Chen, C. C. Tzeng, I. S. Chen, Helv. Chim. Acta 2002, 85, 2214.
2. I. L. Chen, Y. L. Chen, C. C. Tzeng, Chin. Pharm. J. 2003, 55, 49.
3. Y. L. Zhao, Y. L. Chen, C.,C. Tzeng, I. L. Chen, T. C. Wang, C. H. Han, Chem. Biodiv. 2005, 2, 205.
4. Y. L. Chen, I. L. Chen, T. C. Wang, C. H. Han, C. C. Tzeng, Eur. J. Med. Chem. 2005, 40, 928.
5. G. J. Atwell, B. F. Cain, R. N. Seelye, J. Med. Chem. 1972, 15, 611.
6. W. A. Denny, B. F. Cain, G. J. Atwell, C. Hansch, A. Panthananickal, A. Leo, J. Med. Chem. 1982, 25, 276.
7. S. A. Gamage, D. P. Figgitt, S. J. Wojcik, R. K. Ralph, A. Ransijn, J. Mauel, V. Yardley, D. Snowdon, S. L. Croft, W. A. Denny, J. Med. Chem. 1997, 40, 2634.
8. J. Stanslas, D. J. Hagan, M. J. Ellis, C. Turner, J. Carmichael, W. Ward, T. R. Hammonds, M. F. G. Stevens, J. Med. Chem. 2000, 43, 1563.
9. J. Y Chang, C. F. Lin, W. Y. Pan, V. Bacherikov, T.-C. Chou, C. H. Chen, H. Dong, S. Y. Cheng, T. J. Tsai, Y. W. Lin, K. T. Chen, L. T. Chen, T. L. Su, Bioorg. Med. Chem. 2003, 11, 4959.
10. C. Alvarez-Ibarra, R. Fernandez-Granda, M. L. Quiroga, A. Carbonell, F. Cardenas, E., Giralt, J. Med. Chem. 1997, 40, 668.
11. P. Rodriguez-Loaiza, A. Quintero, R. Rodriguez-Sotres, J. D. Solano, A. Lira-Rocha, Eur. J. Med Chem. 2004, 39, 5.
12. R. M. Silverstein, F. X. Webster, D. J. Kiemle, 'Spectrometric Identification of Organic Compounds', 7th edn., John Wiley & Sons, New York, 2005, p. 204.
13. S. D. Heo, J. G. Park, K. Hata, R. Day, R. B. Herberman, T. L. Whiteside, Cancer Res. 1990, 50, 3681.
14. S. C Guo, S. C. Huang, L. J. Huang, H. E. Cheng, T. P. Lin, C. H. Wu, J. Heterocycl. Chem. 1991, 28, 955.